|
|||
|
Multiple Sclerosis Info
|
Wednesday, April 30
Restless Leg Syndrome Part 4 of 8
by
multiplesclerosis
on Wed 30 Apr 2008 01:00 AM CST
is generally a lifelong condition for which there is no cure. Symptoms may gradually worsen with age, though more slowly for those more »
Tuesday, April 29
Restless Leg Syndrome Part 3 of 8
by
multiplesclerosis
on Tue 29 Apr 2008 02:00 AM CST
Currently, there is no single diagnostic test for RLS. The disorder is diagnosed clinically by evaluating the patient's history and symptoms. Despite a clear description of clinical features, the condition more »
Monday, April 28
Restless Leg Syndrome Part 2 of 8
by
multiplesclerosis
on Mon 28 Apr 2008 01:00 AM CST
As described above, people with RLS feel uncomfortable sensations in their legs, especially when sitting or lying down, accompanied by an irresistible urge to move about. These sensations more »
Sunday, April 27
Restless Leg Syndrome Part 1 of 8
by
multiplesclerosis
on Sun 27 Apr 2008 03:20 PM CST
Restless legs syndrome (RLS) is a neurological disorder characterized by unpleasant sensations in the legs and an uncontrollable urge to move when more »
List of Upcoming Articles regarding Restless Leg Syndrome
by
multiplesclerosis
on Sun 27 Apr 2008 03:18 PM CST
List of Upcoming Articles regarding Restless Leg Syndrome 1. What Restless Leg Syndrome is 2. What are common signs and symptoms of restless legs? 4. What causes restless legs syndrome? 5. How is restless legs syndrome diagnosed? 6. How is restless legs syndrome treated? 7. What is the prognosis of people with restless legs? 8. What research is being done? 9. Study of Pramipexole presented at AAN 10. Drug Information: Pramipexole 11. Where can I get more information? 12. Health Canada Warnings of Dietary Supplements for RLS Wednesday, April 2
Drug Trial - Patch for Restless Leg Syndrome
by
multiplesclerosis
on Wed 02 Apr 2008 12:00 AM CST
This trial is an open label extension of a six-arm, double-blind, prospective, placebo-controlled, 7 week, dose-finding study in 33 centers in Europe. The aim of this trial is to determine safety, tolerability and efficacy of long-term application in subjects with moderate to more »
|
||
